p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2014-06-18
DOI
10.1155/2014/717919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Mdm Network and Its Regulation of p53 Activities: A Rheostat of Cancer Risk
- (2014) Christine M. Eischen et al. HUMAN MUTATION
- p53 haploinsufficiency and functional abnormalities in multiple myeloma
- (2014) P J Teoh et al. LEUKEMIA
- Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma
- (2013) Silvia Mangiacavalli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting p53 by small molecules in hematological malignancies
- (2013) Manujendra N Saha et al. Journal of Hematology & Oncology
- Management of multiple myeloma in Asia: resource-stratified guidelines
- (2013) Daryl Tan et al. LANCET ONCOLOGY
- PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
- (2013) Manujendra N. Saha et al. MOLECULAR CANCER THERAPEUTICS
- ARF Represses Androgen Receptor Transactivation in Prostate Cancer
- (2013) Wenfu Lu et al. MOLECULAR ENDOCRINOLOGY
- Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer
- (2013) Sumaira Amir et al. PLoS One
- p53 Nuclear Expression Correlates With Hemizygous TP53 Deletion and Predicts an Adverse Outcome for Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide
- (2012) Mei-Hsi Chen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
- (2012) S. Surget et al. CANCER RESEARCH
- Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB
- (2012) Carolina Vicente-Dueñas et al. CELL CYCLE
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
- (2012) Angela M Sosin et al. Journal of Hematology & Oncology
- Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated by Point Mutations of p53, but Can Be Overcome with the p53 Targeting Agent RITA
- (2012) R. J. Jones et al. MOLECULAR CANCER THERAPEUTICS
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma
- (2012) Manujendra N. Saha et al. PLoS One
- PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
- (2011) R. Zandi et al. CLINICAL CANCER RESEARCH
- The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy
- (2011) Kevin D. Boyd et al. GENES CHROMOSOMES & CANCER
- Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
- (2011) Rosa Linda Messina et al. INTERNATIONAL JOURNAL OF CANCER
- Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
- (2011) M H Aziz et al. ONCOGENE
- MicroRNAs: New Players in Multiple Myeloma
- (2011) Flavia Pichiorri et al. Frontiers in Genetics
- Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma
- (2010) Manujendra N. Saha et al. CANCER BIOLOGY & THERAPY
- Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
- (2010) J. Chung et al. CURRENT DRUG TARGETS
- Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma
- (2010) L. Lode et al. HAEMATOLOGICA
- The role of mutant p53 in human cancer
- (2010) Amanda M Goh et al. JOURNAL OF PATHOLOGY
- RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses
- (2010) M. N. Saha et al. MOLECULAR CANCER THERAPEUTICS
- Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
- (2010) Wenwei Hu et al. MOLECULAR CELL
- Translating p53 into the clinic
- (2010) Chit Fang Cheok et al. Nature Reviews Clinical Oncology
- Negative regulation of the tumor suppressor p53 gene by microRNAs
- (2010) M Kumar et al. ONCOGENE
- DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance
- (2009) Carmen Stanganelli et al. ANNALS OF HEMATOLOGY
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- MicroRNA-125b is a novel negative regulator of p53
- (2009) M. T.N. Le et al. GENES & DEVELOPMENT
- Pharmacological activation of the p53 pathway in haematological malignancies
- (2009) M. N Saha et al. JOURNAL OF CLINICAL PATHOLOGY
- Hematopathology
- (2009) MODERN PATHOLOGY
- An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals
- (2009) Ramzi M Mohammad et al. Molecular Cancer
- Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
- (2009) J M R Lambert et al. ONCOGENE
- Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
- (2009) Nerea Allende-Vega et al. SEMINARS IN CANCER BIOLOGY
- An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma
- (2008) W. Xiong et al. BLOOD
- Targeting the MDM2-p53 Interaction for Cancer Therapy
- (2008) S. Shangary et al. CLINICAL CANCER RESEARCH
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started